07:00 , Apr 20, 2015 |  BC Week In Review  |  Financial News

Innocrin Pharmaceuticals completes venture financing

Innocrin Pharmaceuticals Inc., Durham, N.C.   Business: Cancer   Date completed: 2015-04-14   Type: Venture financing   Raised: $28 million   Investors: Eshelman Ventures; Novartis Venture Funds; Lilly Ventures; Hatteras Venture Partners; Intersouth Partners; A&B Equity Holdings   ...